Jim Cramer's 6 Stocks in 60 Seconds: BUD S LNG VJET SGEN CROX

Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".

(Updates from 11:04 a.m. ET with closing information.)

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Wednesday.

Goldman Sachs upgraded Anheuser-Busch (BUD) to buy from sell. Cramer said that any time he sees a big upgrade like that, he knows the company has likely got something proprietary. "I'd be a buyer" ahead of earnings on Feb. 26, he said. BUD was up 11 cents at $99.78.

Sprint (S) continues to move higher for a second day based on its earnings. Deutsche Bank upgraded the stock to buy from hold. Cramer commented, "This is not an earnings story, but they're trying to make it one." S rose 2.2% to $8.03.

Cheniere Energy (LNG) continues to get "approval after approval" on what Cramer called one of the biggest projects in the country, which is the exporting of liquified natural gas. He said the company has a four-year head start on its competition in this field. LNG was 2.2% higher at $45.84.

Citigroup cut its price target on Voxeljet (VJET) to $38 from $55. Cramer said the 3-D printing space is "dangerous," with the exception of Stratasys (SSYS). VJET dropped 5.5% to $34.90.

Seattle Genetics (SGEN) could be the next Regeneron Pharmaceuticals (REGN) or Celgene (CELG), Cramer said of the $5 billion market-cap company. He said Seattle Genetics just reported a "fantastic number" on its earnings report. SGEN vaulted 10.7% to $50.49.

If you liked this article you might like

10 Winter Beers Here Before Halloween

Democrats Target Megamergers in Populist Political Play

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief

Corporate America Wants a Piece of the Mayweather, McGregor Money Giveaway

With Eyes on Solar Eclipse, Wall Street Stumbles Yet Again